BCPC Quote, Financials, Valuation and Earnings

Friedman Industries has a net margin of 14.79% compared to Balchem's net margin of 4.14%. Balchem's return on equity of 11.92% beat Friedman Industries's return on equity of 4.71%.

Balchem has a consensus price target of $196.00, signalling upside risk potential of 23.94%. On the other hand Friedman Industries has an analysts' consensus of -- which suggests that it could fall by --. Given that Balchem has higher upside potential than Friedman Industries, analysts believe Balchem is more attractive than Friedman Industries.

Balchem has a beta of 0.891, which suggesting that the stock is 10.888% less volatile than S&P 500. In comparison Friedman Industries has a beta of 1.485, suggesting its more volatile than the S&P 500 by 48.545%.

Balchem has a quarterly dividend of $0.87 per share corresponding to a yield of 0.55%. Friedman Industries offers a yield of 1.02% to investors and pays a quarterly dividend of $0.04 per share. Balchem pays 19.91% of its earnings as a dividend. Friedman Industries pays out 18.32% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

Balchem quarterly revenues are $250.5M, which are larger than Friedman Industries quarterly revenues of $129.2M. Balchem's net income of $37.1M is higher than Friedman Industries's net income of $5.3M. Notably, Balchem's price-to-earnings ratio is 37.92x while Friedman Industries's PE ratio is 18.21x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Balchem is 5.37x versus 0.24x for Friedman Industries. Usually stocks with elevated PS ratios are considered overvalued.

Innospec has a net margin of 14.79% compared to Balchem's net margin of 7.44%. Balchem's return on equity of 11.92% beat Innospec's return on equity of 2.21%.

Balchem has a consensus price target of $196.00, signalling upside risk potential of 23.94%. On the other hand Innospec has an analysts' consensus of $115.00 which suggests that it could grow by 36.05%. Given that Innospec has higher upside potential than Balchem, analysts believe Innospec is more attractive than Balchem.

Balchem has a beta of 0.891, which suggesting that the stock is 10.888% less volatile than S&P 500. In comparison Innospec has a beta of 1.047, suggesting its more volatile than the S&P 500 by 4.676%.

Balchem has a quarterly dividend of $0.87 per share corresponding to a yield of 0.55%. Innospec offers a yield of 1.93% to investors and pays a quarterly dividend of $0.84 per share. Balchem pays 19.91% of its earnings as a dividend. Innospec pays out 108.99% of its earnings as a dividend. Balchem's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future, but Innospec's is not.

Balchem quarterly revenues are $250.5M, which are smaller than Innospec quarterly revenues of $440.8M. Balchem's net income of $37.1M is higher than Innospec's net income of $32.8M. Notably, Balchem's price-to-earnings ratio is 37.92x while Innospec's PE ratio is 79.75x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Balchem is 5.37x versus 1.19x for Innospec. Usually stocks with elevated PS ratios are considered overvalued.

Paramount Gold Nevada has a net margin of 14.79% compared to Balchem's net margin of --. Balchem's return on equity of 11.92% beat Paramount Gold Nevada's return on equity of --.

Balchem has a consensus price target of $196.00, signalling upside risk potential of 23.94%. On the other hand Paramount Gold Nevada has an analysts' consensus of $1.70 which suggests that it could grow by 149.19%. Given that Paramount Gold Nevada has higher upside potential than Balchem, analysts believe Paramount Gold Nevada is more attractive than Balchem.

Balchem has a beta of 0.891, which suggesting that the stock is 10.888% less volatile than S&P 500. In comparison Paramount Gold Nevada has a beta of 1.135, suggesting its more volatile than the S&P 500 by 13.451%.

Balchem has a quarterly dividend of $0.87 per share corresponding to a yield of 0.55%. Paramount Gold Nevada offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Balchem pays 19.91% of its earnings as a dividend. Paramount Gold Nevada pays out -- of its earnings as a dividend. Balchem's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Balchem quarterly revenues are $250.5M, which are larger than Paramount Gold Nevada quarterly revenues of --. Balchem's net income of $37.1M is higher than Paramount Gold Nevada's net income of -$2.6M. Notably, Balchem's price-to-earnings ratio is 37.92x while Paramount Gold Nevada's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Balchem is 5.37x versus -- for Paramount Gold Nevada. Usually stocks with elevated PS ratios are considered overvalued.

Solitario Resources has a net margin of 14.79% compared to Balchem's net margin of --. Balchem's return on equity of 11.92% beat Solitario Resources's return on equity of --.

Balchem has a consensus price target of $196.00, signalling upside risk potential of 23.94%. On the other hand Solitario Resources has an analysts' consensus of $1.50 which suggests that it could grow by 128.94%. Given that Solitario Resources has higher upside potential than Balchem, analysts believe Solitario Resources is more attractive than Balchem.

Balchem has a beta of 0.891, which suggesting that the stock is 10.888% less volatile than S&P 500. In comparison Solitario Resources has a beta of 0.465, suggesting its less volatile than the S&P 500 by 53.534%.

Balchem has a quarterly dividend of $0.87 per share corresponding to a yield of 0.55%. Solitario Resources offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Balchem pays 19.91% of its earnings as a dividend. Solitario Resources pays out -- of its earnings as a dividend. Balchem's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Balchem quarterly revenues are $250.5M, which are larger than Solitario Resources quarterly revenues of --. Balchem's net income of $37.1M is higher than Solitario Resources's net income of -$511K. Notably, Balchem's price-to-earnings ratio is 37.92x while Solitario Resources's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Balchem is 5.37x versus -- for Solitario Resources. Usually stocks with elevated PS ratios are considered overvalued.